These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Prognosis
150 results:

  • 1. Identification of a gene expression signature associated with brain metastasis in colorectal cancer.
    Michl M; Taverna F; Woischke C; Li P; Klauschen F; Kirchner T; Heinemann V; von Bergwelt-Baildon M; Stahler A; Herold TM; Jurinovic V; Engel J; Kumbrink J; Neumann J
    Clin Transl Oncol; 2024 Aug; 26(8):1886-1895. PubMed ID: 38558282
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients who Undergo Resection for colorectal Liver Metastases.
    Laroche S; Scatton O; Charlotte F; Bachet JB; Lim C; Fuks D; Goumard C
    Ann Surg Oncol; 2024 Jul; 31(7):4436-4444. PubMed ID: 38549003
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeted Mass Spectrometry Analyses of Somatic Mutations in colorectal cancer Specimens Using Differential Ion Mobility.
    Wu Z; Bonneil É; Belford M; Boeser C; Dunyach JJ; Thibault P
    J Proteome Res; 2024 Feb; 23(2):644-652. PubMed ID: 38153093
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Small molecular inhibitors for KRAS-mutant cancers.
    Wu X; Song W; Cheng C; Liu Z; Li X; Cui Y; Gao Y; Li D
    Front Immunol; 2023; 14():1223433. PubMed ID: 37662925
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. KRAS Pathways: A Potential Gateway for cancer Therapeutics and Diagnostics.
    Tripathi PK; Mittal KR; Jain N; Sharma N; Jain CK
    Recent Pat Anticancer Drug Discov; 2024; 19(3):268-279. PubMed ID: 37038676
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An empirical review on the resistance mechanisms of epidermal growth factor receptor inhibitors and predictive molecular biomarkers in colorectal cancer.
    Bhattacharya S
    Crit Rev Oncol Hematol; 2023 Mar; 183():103916. PubMed ID: 36717006
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Morbidity and long-term results in patients with wild and mutant type Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations undergoing colorectal cancer surgery.
    Aziret M; Subasi O; Bilir C; Tozlu M; Altıntoprak F; Karaman K; Ercan M; Celebi F
    Ann Ital Chir; 2022; 92():65-77. PubMed ID: 35342104
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular Pathways Associated with Kallikrein 6 Overexpression in colorectal cancer.
    Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Is the Effect of Tumor Localization on prognosis Compatible with Real-life Data in Metastatic Colon cancer? Single-Center Experience: A Retrospective Analysis.
    Oytun MG; Bulut G; Gökmen E
    J Gastrointest Cancer; 2022 Mar; 53(1):7-15. PubMed ID: 33665720
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The role of circulating tumor cells and k-ras mutations in patients with locally advanced rectal cancer: a prospective study.
    Bahnassy AA; Abdel-Azim YA; Ezzat S; Abdellateif MS; Zekri AN; Mohanad M; Salama A; Khaled H
    Mol Biol Rep; 2020 Dec; 47(12):9645-9657. PubMed ID: 33174084
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Small Molecule Destabilizer of β-Catenin and Ras Proteins Antagonizes Growth of k-ras Mutation-Driven colorectal cancers Resistant to EGFR Inhibitors.
    Choi JK; Cho H; Moon BS
    Target Oncol; 2020 Oct; 15(5):645-657. PubMed ID: 33026592
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis.
    Ye ZL; Qiu MZ; Tang T; Wang F; Zhou YX; Lei MJ; Guan WL; He CY
    Cancer Med; 2020 Jan; 9(2):745-756. PubMed ID: 31782259
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study.
    Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS; Khalil AA
    Saudi Med J; 2019 May; 40(5):432-439. PubMed ID: 31056618
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score (mCCS).
    Marschner N; Frank M; Vach W; Ladda E; Karcher A; Winter S; Jänicke M; Trarbach T
    Colorectal Dis; 2019 Jul; 21(7):816-826. PubMed ID: 30834622
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
    Qian F; Xiao J; Gai L; Zhu J
    Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group.
    Goey KKH; Sørbye H; Glimelius B; Adams RA; André T; Arnold D; Berlin JD; Bodoky G; de Gramont A; Díaz-Rubio E; Eng C; Falcone A; Grothey A; Heinemann V; Hochster HS; Kaplan RS; Kopetz S; Labianca R; Lieu CH; Meropol NJ; Price TJ; Schilsky RL; Schmoll HJ; Shacham-Shmueli E; Shi Q; Sobrero AF; Souglakos J; Van Cutsem E; Zalcberg J; van Oijen MGH; Punt CJA; Koopman M
    Eur J Cancer; 2018 Sep; 100():35-45. PubMed ID: 29936065
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Bevacuzimab May Be Less Effective in Obese Metastatic colorectal cancer Patients.
    Artaç M; Korkmaz L; Coşkun HŞ; Dane F; Karabulut B; Karaağaç M; Çabuk D; Karabulut S; Aykan NF; Doruk H; Avcı N; Turhal NS
    J Gastrointest Cancer; 2019 Jun; 50(2):214-220. PubMed ID: 29302856
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Critical Role of p53 and k-ras in the Diagnosis of Early colorectal cancer: a One-year, Single-center Analysis.
    Lu HY; Lin RT; Zhou GX; Yu TM; Liu ZJ
    Int J Med Sci; 2017; 14(11):1154-1162. PubMed ID: 29104470
    [No Abstract]    [Full Text] [Related]  

  • 20. Tumor regression grades, k-ras mutational profile and c-MET in colorectal liver metastases.
    Lorenzon L; Ricca L; Pilozzi E; Lemoine A; Riggio V; Giudice MT; Mallel G; Fochetti F; Balducci G
    Pathol Res Pract; 2017 Aug; 213(8):1002-1009. PubMed ID: 28559118
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.